 |
 |
After starting out with all the extreme measures that go with suspected Lassa or Ebola virus infection, which are in the line of the measures stated in the CDC guidelines ( <http://www.cdc.gov/ncidod/sars/lab.htm> http://www.cdc.gov/ncidod/sars/lab.htm ), the infection committee of our hospital, headed by the Corona virus expert Prof. W. Spaan, decided (as SARS turned out to be caused by a corona virus), that standard safety precautions to avoid HIV or Hepatitis B infection are sufficient when handling blood or urine for routine clinical chemistry and hematology. This is also the essence of the guidelines in ( <http://www.phls.org.uk/topics_az/SARS/Clinical_guidance.htm> http://www.phls.org.uk/topics_az/SARS/Clinical_guidance.htm ). The only extra precaution that is taken, is that all samples from patients (suspected) with SARS are desinfected externally before leaving the patients room. Right now news comes in that the clinical picture of SARS is shifting towards gastro intestinal infection, which may prompt us to handle feaces and urine with extra care ?!! Bart Ballieux Dr.Ir. B.E.P.B. Ballieux Klinisch Chemicus CKCL, E2-P Leids Universitair Medisch Centrum Postbus 9600 2300 RC Leiden Tel: 071-5262165/2278 Fax: 071-5266753 email: [log in to unmask] -----Original Message----- From: Chris Lovell-Smith [mailto:[log in to unmask]] Sent: donderdag 24 april 2003 04:02 To: [log in to unmask] Subject: Re: SARS Precautions These and other guidelines seem to mainly cover taking appropriate micro/viro specimens and subsequent handling up to the point of setting up tests. We are trying to work out what to do about ABG's, for example: sampling into the analyser can sometimes be a bit messy, and is disposal of the sample mixed with machine solutions OK if continued as usual? Should lab staff doing ABG's wear more protective clothing than usual? I'd like to hear other's views/questions. Dr Chris Lovell-Smith Clinical Leader and Chemical Pathologist Otago Diagnostic Laboratories, Dunedin Hospital, Dunedin, NZ. Phone 64 3 474 7925 Fax 64 3 474 7637 -----Original Message----- From: O'Connor.John [mailto:[log in to unmask]] Sent: Wednesday, 23 April 2003 2:03 To: [log in to unmask] Subject: SARS Precautions Some good guidelines from the CDC <http://www.cdc.gov/ncidod/sars/lab.htm> http://www.cdc.gov/ncidod/sars/lab.htm John O'Connor _____ Attention: This e-mail is privileged and confidential. If you are not the intended recipient please delete the message and notify the sender. Any views or opinions presented are solely those of the author. _____ ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/ ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/